Dangerous waters: Geopolitics, supply chains and access to medicines
The Middle East conflict has accentuated long-standing vulnerabilities in the pharma manufacturing supply chain.
Supply chain
Why pharma manufacturers are still investing in Europe
Can pharma tariffs “Make America Manufacture Again”?
Are European biopharma manufacturers ‘nearshoring’?
UK charities condemn continued drug shortages
Samsung poses threat to Taiwan’s ‘silicon shield’
Legislation last resort to tackle fashion brands’ ongoing transparency failures
